Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11186407rdf:typepubmed:Citationlld:pubmed
pubmed-article:11186407lifeskim:mentionsumls-concept:C1261473lld:lifeskim
pubmed-article:11186407lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11186407lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:11186407lifeskim:mentionsumls-concept:C0240951lld:lifeskim
pubmed-article:11186407lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:11186407lifeskim:mentionsumls-concept:C0205276lld:lifeskim
pubmed-article:11186407lifeskim:mentionsumls-concept:C1578536lld:lifeskim
pubmed-article:11186407lifeskim:mentionsumls-concept:C0686907lld:lifeskim
pubmed-article:11186407pubmed:issue5lld:pubmed
pubmed-article:11186407pubmed:dateCreated2001-1-19lld:pubmed
pubmed-article:11186407pubmed:abstractTextFrom the Scandinavian Sarcoma Group Register, information on 1,224 surgically-treated patients with soft tissue sarcoma (STS) of the extremity or trunk wall, diagnosed between 1987 and 1995, was collected. 205 patients, one third of whom were referred to a center with a local recurrence, had a total of 284 local recurrences. This analysis describes the treatment for these local recurrences, complications and risk of further recurrences. 169 patients were surgically treated for their first local recurrence. An intralesional or marginal margin was achieved in 110 of these patients, 59 of whom were also given radiotherapy. 54 of the 169 patients had a second local recurrence. The second local recurrence rate was 0.50 if the first local recurrence had been treated with only surgery with a marginal margin, compared to 0.28 if treated with surgery with a marginal margin and radiotherapy or with a wide margin (p = 0.0008). In extremity STS, the crude amputation rate for local recurrences was 0.22 (31 of 142)-i.e., higher than for primary tumors 0.09 (96 of 1065) (p < 0.0001). A high local recurrence rate after treatment outside of sarcoma centers has earlier been shown. We conclude that the consequences of local recurrence in terms of morbidity and costs justifies referral of STS patients for multidisciplinary evaluation and multimodality treatment.lld:pubmed
pubmed-article:11186407pubmed:languageenglld:pubmed
pubmed-article:11186407pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11186407pubmed:citationSubsetIMlld:pubmed
pubmed-article:11186407pubmed:statusMEDLINElld:pubmed
pubmed-article:11186407pubmed:monthOctlld:pubmed
pubmed-article:11186407pubmed:issn0001-6470lld:pubmed
pubmed-article:11186407pubmed:authorpubmed-author:BauerH CHClld:pubmed
pubmed-article:11186407pubmed:authorpubmed-author:KleppRRlld:pubmed
pubmed-article:11186407pubmed:authorpubmed-author:BerlinOOlld:pubmed
pubmed-article:11186407pubmed:authorpubmed-author:RaabeNNlld:pubmed
pubmed-article:11186407pubmed:authorpubmed-author:GustafsonPPlld:pubmed
pubmed-article:11186407pubmed:authorpubmed-author:WahlströmOOlld:pubmed
pubmed-article:11186407pubmed:authorpubmed-author:ErlansonMMlld:pubmed
pubmed-article:11186407pubmed:authorpubmed-author:SaeterGGlld:pubmed
pubmed-article:11186407pubmed:authorpubmed-author:TrovikC SCSlld:pubmed
pubmed-article:11186407pubmed:issnTypePrintlld:pubmed
pubmed-article:11186407pubmed:volume71lld:pubmed
pubmed-article:11186407pubmed:ownerNLMlld:pubmed
pubmed-article:11186407pubmed:authorsCompleteYlld:pubmed
pubmed-article:11186407pubmed:pagination488-95lld:pubmed
pubmed-article:11186407pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:meshHeadingpubmed-meshheading:11186407...lld:pubmed
pubmed-article:11186407pubmed:year2000lld:pubmed
pubmed-article:11186407pubmed:articleTitleConsequences of local recurrence of soft tissue sarcoma: 205 patients from the Scandinavian Sarcoma Group Register.lld:pubmed
pubmed-article:11186407pubmed:affiliationDepartment of Orthopedics, Haukeland Hospital, Bergen, Norway. cstr@haukeland.nolld:pubmed
pubmed-article:11186407pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11186407pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed